A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese
Clinical trial NCT06132841 · COMPLETED
Trial details
- NCT number
- NCT06132841
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-13
- Primary completion
- 2026-02-03
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.